Can I Take St. John's Wort with Zepbound?

At a glance

  • Zepbound label and CYP enzymes / Tirzepatide is not broken down by CYP enzymes; St. John's wort is not named in the label's interaction section [1]
  • St. John's wort mechanism / Activates PXR, inducing CYP3A4 and P-glycoprotein [3]
  • Size of that effect / Oral midazolam clearance rose 1.96- to 5.62-fold across 300 to 1,800 mg a day [4]
  • Biggest concern here / Oral hormonal contraceptives [1][2]
  • Zepbound label advice / Non-oral method or added barrier method for 4 weeks after start and after each dose increase [1]
  • Other drugs the herb weakens / Warfarin, cyclosporine, digoxin, amitriptyline, simvastatin [5][6][7][8][9]
  • Bottom line / The herb is not expected to touch tirzepatide itself, but it can undercut other prescriptions

Does St. John's wort change tirzepatide levels?

The Zepbound label says tirzepatide is metabolized by proteolytic cleavage of the peptide backbone, beta-oxidation of the fatty diacid and amide hydrolysis, not by CYP enzymes, and that it has low in vitro potential to inhibit or induce CYP enzymes [1]. St. John's wort acts mainly by inducing CYP3A4 and P-glycoprotein [3]. Median time to peak concentration is 24 hours, absolute bioavailability is 80%, about 99% is albumin bound, and the half-life is roughly 5 days [1]. Zepbound is given as a once-weekly subcutaneous injection [1].

How strong is the enzyme induction?

St. John's wort activates the pregnane X receptor, which switches on CYP3A4 and other cytochrome P450 enzymes plus P-glycoprotein [3]. The size of the effect depends on the dose and the product, and specifically on its hyperforin content [3][10]. Measured in people:

  • In 11 healthy volunteers, 14 days of St. John's wort raised oral midazolam clearance 1.96-fold at 300 mg a day, 3.86-fold at 900 mg a day and 5.62-fold at 1,800 mg a day [4].
  • In 42 men given one of six products for 14 days, midazolam exposure fell 79.4% with an extract supplying 41 mg of hyperforin a day, 47.9% with a powder supplying 12 mg a day, and 21.1% with a powder supplying 0.13 mg a day [10]. The effect correlated with hyperforin dose, not hypericin [10].
  • In 12 volunteers taking 300 mg three times daily for 14 days, alprazolam exposure fell by half and its half-life dropped from 12.4 to 6.0 hours [11].

The milligram amount on a label says little on its own; across products, the hyperforin dose is what tracked the size of the effect [10].

What happens with birth control pills?

The Zepbound label says use may reduce the efficacy of oral hormonal contraceptives because of delayed gastric emptying, which is largest after the first dose and diminishes over time. It advises a non-oral method or an added barrier method for 4 weeks after starting and for 4 weeks after each dose escalation; non-oral hormonal contraceptives should not be affected [1]. In the label's study of a single 5 mg dose with a combined pill, peak levels of ethinyl estradiol, norgestimate and norelgestromin fell 59%, 66% and 55%, and total exposure fell 20% to 23% [1].

St. John's wort acts on the same pill by a different route. In a randomized trial of 18 women using a pill with 0.02 mg ethinyl estradiol and 0.15 mg desogestrel, adding 300 mg of extract twice daily produced intracyclic bleeding in 13 of 17 (77%) and three times daily in 15 of 17 (88%), against 6 of 17 (35%) on the pill alone. Exposure to the active progestin metabolite fell 43.9% and 41.7%, ethinyl estradiol levels were unchanged, and there was no evidence of ovulation [2]. A systematic review of four such studies found more breakthrough bleeding in three, increased follicular growth with probable ovulation in one, and lower hormone exposure in three [12]. The Sprintec (norgestimate and ethinyl estradiol) label names products containing St. John's wort among those that may lower combined-pill concentrations and says to continue back-up contraception for 28 days after the inducer is stopped [13].

Which other prescriptions are affected?

The Zepbound label says to monitor oral medicines that depend on threshold concentrations for effect, and those with a narrow therapeutic index such as warfarin, when given with Zepbound [1]. St. John's wort has separately been shown to lower exposure to several oral medicines:

  • Warfarin: in 12 healthy men given a single 25 mg dose, 14 days of St. John's wort raised S-warfarin clearance by 29% and lowered the INR area under the curve to 0.79 of baseline (90% CI 0.70 to 0.95) [5]. The warfarin label lists St. John's wort among botanicals that may decrease its effect [14].
  • Cyclosporine: in 11 kidney transplant recipients, 600 mg a day of extract for 14 days lowered dose-corrected cyclosporine exposure by 46%, peak by 42% and trough by 41%. The cyclosporine dose was raised from a median of 2.7 to 4.2 mg/kg/day, with the first adjustment 3 days after starting the herb [6].
  • Digoxin: in a placebo-controlled study, 10 days of extract at 900 mg a day lowered digoxin exposure by 25%, trough by 33% and peak by 26% [7].
  • Rivaroxaban: after 2 weeks of extract in 12 volunteers, exposure fell to 0.76 of baseline and factor Xa inhibition to 0.80 [15].
  • Amitriptyline: in 12 patients, adding extract lowered amitriptyline exposure by 22% and nortriptyline by 41% [8].

NCCIH's list of medicines the herb can weaken includes antidepressants, birth control pills, cyclosporine, some anti-seizure drugs, some heart, HIV and cancer drugs, warfarin and certain statins including simvastatin [9].

What about antidepressants and other serotonin-affecting drugs?

NCCIH says that taking St. John's wort with certain antidepressants or other drugs that affect serotonin may lead to increased serotonin-related side effects, which can be serious [9].

What the Zepbound label actually flags

The label's interaction section covers two things: insulin and insulin secretagogues such as sulfonylureas, where a lower dose may be considered to reduce hypoglycemia risk, and oral medicines generally, where delayed gastric emptying may change absorption, with specific advice on oral contraceptives [1]. St. John's wort is not named in that section [1].

For someone taking both, the practical points are which oral contraceptive is in use and whether a non-oral or barrier method covers the 4-week windows after starting Zepbound and after each dose escalation [1], and whether a narrow-therapeutic-index oral drug such as warfarin is on the medication list, given that St. John's wort lowers warfarin's effect [5][14].

Frequently asked questions

Can I take St. John's wort with Zepbound?
The Zepbound label does not name St. John's wort, and it says tirzepatide is broken down by proteolytic cleavage and beta-oxidation rather than by CYP enzymes [1]. The concern is the rest of the regimen: St. John's wort induces CYP3A4 and P-glycoprotein and lowers exposure to many other drugs, including oral contraceptives [3][2].
Does St. John's wort reduce Zepbound's weight loss effect?
The label's pharmacokinetic data do not point to such an effect, since tirzepatide is not a CYP substrate and has a half-life of about 5 days after subcutaneous injection [1]. For reference, in SURMOUNT-1, 72 weeks of tirzepatide produced mean weight changes of -15.0%, -19.5% and -20.9% at 5, 10 and 15 mg versus -3.1% on placebo [16].
Can St. John's wort make birth control pills fail while on Zepbound?
Both can reduce oral contraceptive effectiveness by different mechanisms. The Zepbound label says delayed gastric emptying may reduce oral contraceptive efficacy and advises a non-oral method or added barrier method for 4 weeks after starting and after each dose escalation [1]. In one trial, St. John's wort raised intracyclic bleeding to 77% and 88% versus 35% and cut progestin exposure by about 42% to 44% [2].
How long should back-up contraception continue after stopping St. John's wort?
The Sprintec combined oral contraceptive label advises continuing back-up contraception for 28 days after an enzyme inducer, a group that includes products containing St. John's wort, is discontinued [13].
Is St. John's wort effective for depression?
NCCIH says it may be helpful for mild or moderate depression, with uncertainty for severe depression or use beyond 12 weeks [9]. A Cochrane review of 29 trials and 5,489 patients found response rates similar to SSRIs (rate ratio 1.00, 95% CI 0.90 to 1.11) and fewer dropouts for adverse effects than SSRIs (odds ratio 0.53) [17].
Which other medicines matter most with this pair?
Warfarin is the clearest example: the Zepbound label asks for monitoring of narrow-therapeutic-index oral drugs [1], and St. John's wort lowered the INR area under the curve to 0.79 of baseline in a 12-person study [5]. Cyclosporine exposure fell 46% in 11 transplant patients [6], digoxin exposure fell 25% over 10 days [7], and NCCIH lists simvastatin among statins the herb can weaken [9].

References

  1. U.S. National Library of Medicine, DailyMed. Zepbound injection (tirzepatide) prescribing information. Zepbound injection (tirzepatide) label
  2. Pfrunder A, Schiesser M, Gerber S, Haschke M, Bitzer J, Drewe J. Interaction of St John's wort with low-dose oral contraceptive therapy: a randomized controlled trial. Br J Clin Pharmacol. 2003;56(6):683-90. Interaction of St John's wort with low-dose oral contraceptive therapy: a randomized controlled trial
  3. Nicolussi S, Drewe J, Butterweck V, Meyer Zu Schwabedissen HE. Clinical relevance of St. John's wort drug interactions revisited. Br J Pharmacol. 2020;177(6):1212-1226. Clinical relevance of St. John's wort drug interactions revisited
  4. Hohmann N, Friedrichs AS, Burhenne J, Blank A, Mikus G, Haefeli WE. Dose-dependent induction of CYP3A activity by St. John's wort alone and in combination with rifampin. Clin Transl Sci. 2024;17(8):e70007. Dose-dependent induction of CYP3A activity by St. John's wort alone and in combination with rifampin
  5. Jiang X, Williams KM, Liauw WS, Ammit AJ, Roufogalis BD, Duke CC, et al. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol. 2004;57(5):592-9. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects
  6. Bauer S, Störmer E, Johne A, Krüger H, Budde K, Neumayer HH, et al. Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John's wort in renal transplant patients. Br J Clin Pharmacol. 2003;55(2):203-11. Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John's wort in renal transplant patients
  7. Johne A, Brockmöller J, Bauer S, Maurer A, Langheinrich M, Roots I. Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum). Clin Pharmacol Ther. 1999;66(4):338-45. Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum)
  8. Johne A, Schmider J, Brockmöller J, Stadelmann AM, Störmer E, Bauer S, et al. Decreased plasma levels of amitriptyline and its metabolites on comedication with an extract from St. John's wort ( Hypericum perforatum ). J Clin Psychopharmacol. 2002;22(1):46-54. Decreased plasma levels of amitriptyline and its metabolites on comedication with an extract from St. John's wort ( Hypericum perforatum )
  9. St. John’s Wort: Usefulness and Safety | NCCIH. St. John’s Wort: Usefulness and Safety | NCCIH
  10. Mueller SC, Majcher-Peszynska J, Uehleke B, Klammt S, Mundkowski RG, Miekisch W, et al. The extent of induction of CYP3A by St. John's wort varies among products and is linked to hyperforin dose. Eur J Clin Pharmacol. 2006;62(1):29-36. The extent of induction of CYP3A by St. John's wort varies among products and is linked to hyperforin dose
  11. Markowitz JS, Donovan JL, DeVane CL, Taylor RM, Ruan Y, Wang JS, et al. Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. JAMA. 2003;290(11):1500-4. Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme
  12. Berry-Bibee EN, Kim MJ, Tepper NK, Riley HE, Curtis KM. Co-administration of St. John's wort and hormonal contraceptives: a systematic review. Contraception. 2016;94(6):668-677. Co-administration of St. John's wort and hormonal contraceptives: a systematic review
  13. U.S. National Library of Medicine, DailyMed. Sprintec norgestimate and ethinyl estradiol tablets (Teva) prescribing information. Sprintec norgestimate and ethinyl estradiol tablets (Teva) label
  14. U.S. National Library of Medicine, DailyMed. Jantoven (warfarin sodium) prescribing information. Jantoven (warfarin sodium) label
  15. Scholz I, Liakoni E, Hammann F, Grafinger KE, Duthaler U, Nagler M, et al. Effects of Hypericum perforatum (St John's wort) on the pharmacokinetics and pharmacodynamics of rivaroxaban in humans. Br J Clin Pharmacol. 2021;87(3):1466-1474. Effects of Hypericum perforatum (St John's wort) on the pharmacokinetics and pharmacodynamics of rivaroxaban in humans
  16. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. Tirzepatide Once Weekly for the Treatment of Obesity
  17. Linde K, Berner MM, Kriston L. St John's wort for major depression. Cochrane Database Syst Rev. 2008;2008(4):CD000448. St John's wort for major depression
Evidence overview for Can I Take St. John's Wort with Zepbound?